Healthcare Private Equity

Our results-oriented, business-minded deal attorneys work seamlessly with our nationally ranked healthcare regulatory attorneys to help private equity clients and their portfolio companies achieve their strategic goals. Clients rely on our deep understanding of healthcare law and our significant experience navigating the unique regulatory and business environment of the healthcare industry.

Since 2015, we have served as deal counsel in more than 150 private equity related transactions in the healthcare industry. We regularly assist private equity firms and their healthcare portfolio companies in structuring, negotiating and executing acquisitions and financings and in dispositions of healthcare investments through sales, recapitalizations and public offerings. Private equity firms utilize our comprehensive due diligence of healthcare targets to help uncover and assess key issues and regulatory and compliance risks associated with an investment and rely on the sophisticated guidance of our healthcare regulatory and compliance and investigations counsel. In addition, we have extensive experience representing private equity funds providing senior and subordinate credit facilities in connection with their investments, as well as negotiating credit facilities on behalf of sponsors, including acquisition and capital call facilities.

We advise investors, portfolio companies and management teams in the following:

  • Acquisitions and exits including:
    • Platform and add-on acquisitions.
    • Due diligence and risk analysis.
    • Leveraged dividends and recapitalizations.
    • Leveraged buyouts.
    • Going private transactions.
    • Sponsor-sponsor transactions.
    • Initial public offerings and exit transaction services and preparation.
    • Management team representation and executive compensation matters.
  • Healthcare regulatory and operations.
  • Healthcare compliance and investigations.
  • Financing including minority interest transactions and mezzanine and senior financings.

We also know that our private equity clients want true partners who offer more than legal advice. At the intersection of healthcare and private equity, we often connect sponsors with companies or successful executives seeking investment. To that end, we invite managing directors and executive management teams to discuss trends and foster opportunities at our annual Health Care Investors Conference co-hosted with Deloitte. Our attorneys are also active in the Association for Corporate Growth, the Healthcare Private Equity Association (HCPEA), the Nashville Health Care Council and other organizations.

Our healthcare attorneys encompass the multitude of legal specialties necessary to service one of the largest, most highly regulated industries in the United States. We bring our multidisciplinary, team approach to our representation of the following sectors and facilities:

  • Academic medical centers.
  • Addiction treatment.
  • Ambulatory surgery centers.
  • Anesthesiology.
  • Behavioral health.
  • Cancer therapy and oncology.
  • Cardiovascular.
  • Clinical laboratories.
  • Dentistry.
  • Dermatology.
  • Diagnostic imaging.
  • Eye care.
  • Gastrointestinal (GI).
  • Health plans, managed care companies and benefit management companies.
  • Health population management.
  • Healthcare Real Estate Investment Trusts (REITs).
  • Healthcare information technology.
  • Home health.
  • Hospice.
  • Hospitals and health systems.
  • Life sciences.
  • Managed care.
  • Medical device.
  • Nonprofit providers.
  • Orthotics and prosthetics.
  • Pharmaceuticals and pharmacies.
  • Physician practices, outsourced physician services and management companies.
  • Primary care.
  • Radiology.
  • Revenue cycle management.
  • Senior housing and long-term care.
  • Specialty pharmacy and pharmaceuticals.
  • Telemedicine.
  • Urgent and retail care clinics.
  • Wellness and disease management.
  • Women’s care.
  • Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners

    We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
    Read More
    Client Type: Private Company
  • Representation of OneOncology, a community oncology practice management company, in its acquisition of University Oncology Hematology Associates, an oncology practice affiliated with Erlanger hospitals

    We represented OneOncology, a community oncology practice management company, in its acquisition of University Oncology Hematology Associates, an oncology practice...
    Read More
    Client Type: Private Company
  • Representation of Altamont Capital’s portfolio company, Sequel Youth & Family Services, in its acquisition of Pine Cone Therapies, a behavioral healthcare provider with treatment programs to assist those with Autism spectrum, speech-language, intellectual delay, neurological, and attention deficit disorders.

    We represented Altamont Capital’s portfolio company, Sequel Youth & Family Services, in its acquisition of Pine Cone Therapies, a behavioral...
    Read More
    Client Type: Private Company
  • Representation of BRC Recovery in its recapitalization with private investment firms, Veronis Suhler Stevenson (VSS) and NewSpring Health Capital

    We represented BRC Recovery in its recapitalization with private investment firms, Veronis Suhler Stevenson (VSS) and NewSpring Health Capital. BRC...
    Read More
    Client Type: Private Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Read More
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Read More
    Client Type: Private Company
  • Representation of Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare consumer benefits platform. In addition to Health Velocity Capital, other participating investors included U.S. Venture Partners, Chicago Ventures, and Epic Ventures

    We advised Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare...
    Read More
    Client Type: Private Company
  • Representation of Bravo Wellness, a national provider of employee wellness solutions and portfolio company of ABS Capital, in its sale to Medical Mutual, a health insurance company based in Ohio

    We represented Bravo Wellness, an ABS Capital portfolio company, in its sale to Medical Mutual, a health insurance company based...
    Read More
    Client Type: Private Company
  • Representation of TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures in its recapitalization and growth equity investment in InformedDNA, the nation’s largest provider of genetic services

    We represented TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures in its recapitalization and growth equity...
    Read More
    Client Type: Private Company
  • Representation of LucidHealth, a portfolio company of Excellere Partners, in its acquisition of Madison Radiologists

    We represented LucidHealth, a portfolio company of Excellere Partners, in its acquisition of Madison Radiologists. This is the second acquisition...
    Read More
    Client Type: Private Company
Shayan A. Ahmed
Associate
Taylor J. Ashley
Member
Wilmoth H. Baker, IV
Associate
Brian D. Bewley
Member
Robert L. Brewer
Member
Al Bright, Jr.
Member
Emily A. Burrows
Associate
Curtis Capeling
Member
Meredith Edwards Collins
Associate
David Cox
Member
Douglas W. Dahl II
Member
J. Page Davidson
Member
Katie Day
Member
Felix R. Dowsley, III
Member
Kristin C. Dunavant
Counsel
Kaitlyn L. Dunn
Associate
Jeanne Marie Evans
Associate
Curtis L. Fisher
Member
Lara A. Flatau
Member
Leslie M. Ford
Member
John L. Fuller
Member
Michael C. Gibson
Member
Brett Good
Associate
Thomas Gossett
Associate
B. Riney Green
Member
Andrew Hard
Associate
David W. Harper, Jr.
Associate
Brad L. Hart
Associate
Jonathan T. Hasebe
Senior Corporate Attorney
Michael R. Hess
Member
Michael R. Hill
Member
S. Ryan Hoffman
Member
Michael J. Holley
Member
Lauren B. Huddleston
Associate
Angela Humphreys
Member
J. James Jenkins, Jr.
Member
Kris Kemp
Member
Michael R. Kuffner
Member
Howard H. Lamar III
Member
Mark Manner
Member
Elaine C. Naughton
Associate
Jason Northcutt
Member
Andrea N. Orr
Member
J. Allen Overby
Member
Tatjana Paterno
Member
Frank M. Pellegrino
Member
Brianna R. Powell
Associate
Cynthia Y. Reisz
Member
Marc A. Rigsby
Associate
Cynthia N. Sellers
Member
Jonathan D. Stanley
Member
Greg Stevens
Senior Counsel
Michael A. Stewart
Member
Ryan D. Thomas
Member
Shelley R. Thomas
Member
Nesrin Garan Tift
Member
Leigh Walton
Member
Nikki Wethington
Associate
Shannon Wiley
Member